-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Discuss approaches to improve enrollment and outcomes

Program: Spotlight Sessions
Session: Underrepresented minorities in clinical trials for hematologic malignancies: what's the data on the data?
Monday, December 12, 2022, 10:30 AM-11:45 AM

Sikander Ailawadhi

Mayo Clinic, Jacksonville, FL

Disclosures: Ailawadhi: GSK, Sanofi, BMS, Takeda, Beigene, Pharmacyclics, Amgen, Janssen: Consultancy.